Sphera Funds Management Ltd. Sarepta Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

$486 Million
Q4 2024

A detailed history of Sphera Funds Management Ltd. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 98,921 shares of SRPT stock, worth $10.6 Million. This represents 2.48% of its overall portfolio holdings.

Number of Shares

98,921

Previous 125,846 21.4%

Holding current value

$10.6 Million

Previous $15.7 Million 23.48%

% of portfolio

2.48%

Previous 2.88%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$104.54 - $137.94 $2.81 Million - $3.71 Million	-26,925 Reduced 21.4%	98,921 $12 Million
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $5.25 Million - $6.61 Million	42,187 Added 50.43%	125,846 $15.7 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $3.18 Million - $4.6 Million	28,045 Added 50.43%	83,659 $13.2 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $4.04 Million - $6.1 Million	43,114 Added 344.91%	55,614 $7.2 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $2.52 Million - $4.68 Million	-37,500 Reduced 75.0%	12,500 $1.21 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $638,400 - $943,140	6,000 Added 13.64%	50,000 $5.73 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $5.17 Million - $6.86 Million	44,000 New	44,000 $6.06 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $5.42 Million - $12.7 Million	-75,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $12.1 Million - $17.2 Million	-96,500 Reduced 56.27%	75,000 $12.8 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $6.14 Million - $8.32 Million	48,300 Added 39.2%	171,500 $24.1 Million
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $12.5 Million - $23.1 Million	-134,800 Reduced 52.25%	123,200 $19.8 Million
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $9.72 Million - $15.5 Million	118,000 Added 84.29%	258,000 $25.2 Million
Q4 2019 Feb 13, 2020	SELL	$76.53 - $135.58 $8.27 Million - $14.6 Million	-108,038 Reduced 43.56%	140,000 $18.1 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $14.8 Million - $31.9 Million	203,038 Added 451.2%	248,038 $18.7 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $3.19 Million - $4.32 Million	-28,405 Reduced 38.7%	45,000 $0
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $4.6 Million - $6.54 Million	-43,112 Reduced 37.0%	73,405 $8.75 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $3.93 Million - $6.01 Million	40,401 Added 53.08%	116,517 $12.7 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $7.95 Million - $11.1 Million	-68,980 Reduced 47.54%	76,116 $12.3 Million
Q2 2018 Aug 13, 2018	SELL	$71.74 - $153.69 $7.45 Million - $16 Million	-103,901 Reduced 41.73%	145,096 $19.2 Million
Q1 2018 May 10, 2018	SELL	$54.02 - $82.27 $7.35 Million - $11.2 Million	-136,000 Reduced 35.32%	248,997 $18.4 Million
Q3 2017 Nov 09, 2017	BUY	$35.73 - $47.15 $13.8 Million - $18.2 Million	384,997	384,997 $17.5 Million

Others Institutions Holding SRPT

# of Institutions

536

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.38B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Sarepta Therapeutics, Inc. Transaction History